ความเอนเอียงโดยการรายงาน
เชิงอรรถและอ้างอิง

↑  Porta, Miquel, บ.ก. (2008-06-05). A Dictionary of Epidemiology. Oxford University Press. p. 275. ISBN 978-0-19-157844-1. สืบค้นเมื่อ 2013-03-27.
↑  Green, S; Higgins, S (บ.ก.). "Cochrane Handbook for Systematic Reviews of Interventions 4.2.5". องค์กรความร่วมมือคอเครน. Glossary. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2010-03-09. สืบค้นเมื่อ 2015-05-06.{{cite web}}:  CS1 maint: multiple names: editors list (ลิงก์)
↑  doi:10.1186/1745-6215-11-37
This citation will be automatically completed in the next few minutes. You can jump the queue or  บทความเต็มPDF
↑  Doob, C. B. (2013). Social inequality and social stratification in US society. Upper Saddle River, NJ: Pearson.
↑  "Declaration of Helsinki". World Medical Association. เก็บจากแหล่งเดิมเมื่อ 2006-11-29. สืบค้นเมื่อ 2015-05-06. {{cite web}}: ไม่รู้จักพารามิเตอร์ |deadlink= ถูกละเว้น แนะนำ (|url-status=) (help)
↑  Higgins, JPT; Green, S (2008). "Cochrane Handbook for Systematic Review of Interventions". สืบค้นเมื่อ 2015-01-02.
↑  Rosenthal, R (1979). "The file drawer problem and tolerance for null results". Psychological Bulletin. 86 (3).
1 2  Vedula, SS; Goldman, PS; Rona, IJ; Greene, TM; Dickersin, K (2012). "Implementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin litigation". Trials. 13 (136). doi:10.1186/1745-6215-13-136. PMID 22888801.
1 2  Vedula, SS; Bero, L; Scherer, RW; Dickersin, K (2009). "Outcome reporting in industry-sponsored trials for gabapentin for off-label use". N Eng J Med. 361 (120): 1963–1971. doi:10.1056/NEJMsa0906126. PMID 19907043.
↑  Stempel, Jonathan (2014-06-02). "Pfizer to pay $325 million in Neurontin settlement". Reuters. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2014-08-26. สืบค้นเมื่อ 2014-08-24.
↑  Editorial (1909). "The reporting of unsuccessful cases". Boston Medical and Surgical Journal. 161: 263–264. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2014-01-13. สืบค้นเมื่อ 2015-05-06.
1 2  Dickersin, K. (2005). "Publication bias: Recognizing the problem, understanding its origins and scope, and preventing harm".  ใน Rothstein, H.R.; Sutton, A.J.; Borenstein, M. (บ.ก.). Publication bias in meta-analysis: prevention, assessment, and adjustments. London: Wiley. pp. 11-13. ISBN 0470870141.
↑  Godlee, F.; Dickersin, K. (2003). "Bias, subjectivity, chance, and conflict of interest in editorial decisions".  ใน Godlee, F.; Jefferson, T. (บ.ก.). Peer review in health sciences (2nd ed.). London: BMJ Books. ISBN 978-0727916853.
↑  Olson, CM; Rennie, D; Cook, D; Dickersin, K; Flanagin, A; Hogan, JW; Zhu, Q; Reiling, J; Pace, B (2002). "Publication bias in editorial decision making". JAMA. 287 (21): 2825–2828. PMID 12038924.
↑  Song, F; Parekh, S; Hooper, L; Loke, YK; Ryder, J; Sutton, AJ; Hing, C; Kwok, CS; Pang, C; Harvey, I (2010). "Dissemination and publication of research findings: an updated review of related biases". Health Technol Assess. 14 (8): iii, ix–xi. PMID 20181324.
↑  Scherer, RW; Langenberg, P; von Elm, E (2007). "Full publication of results initially presented in abstracts". Cochrane Database Syst Rev. 2: MR000005. doi:10.1002/14651858.MR000005.pub3. PMID 17443628.
1 2 3  Hopewell, S; Clarke, MJ; Stewart, L; Tierney, J (2007). "Time to publication for results of clinical trials". Cochrane Database Syst Rev. 2: MR000011. doi:10.1002/14651858.MR000011.pub2. PMID 17443632.
↑  Hopewell, S; Loudon, K; Clarke, MJ; Oxman, AD; Dickersin, K (2009). "Publication bias in clinical trials due to statistical significance or direction of trial results". Cochrane Database Syst Rev. 1: MR000006. doi:10.1002/14651858.MR000006.pub3. PMID 19160345.
↑  Lundh, A; Sismondo, S; Lexchin, J; Busuioc, OA; Bero, L (2012). "Industry sponsorship and research outcome". Cochrane Database Syst Rev. 12: M R000033. doi:10.1002/14651858.MR000033.pub2.
↑  Von Elm, M; Poglia, G; Walder, B; Tramer, MR (2004). "Different patterns of duplicate publication. An analysis of articles used in systematic reviews". JAMA. 291 (8): 974–980. PMID 14982913.
↑  Easterbrook, PJ; Berlin, JA; Gopalan, R; Matthews, DR (1991). "Publication bias in clinical research". Lancet. 337 (8746): 867–872.
↑  Hopewell, S; McDonald, S; Clarke, MJ; Egger, M (2007). "Grey literature in meta-analyses of randomized trials of health care interventions". Cochrane Database Syst Rev. 2: MR000010. doi:10.1002/14651858.MR000010.pub3. PMID 17443631.
↑  
Gøtzsche, PC (1987). "Reference bias in reports of drug trials". BMJ. 295 (65998): 654–656. PMID 3117277.
↑  
Ravnskov, U (1992). "Frequency of citation and outcome of cholesterol lowering trials". BMJ. 305 (6855): 717.
↑  
Ravnskov, U (1995). "Quotation bias in reviews of the diet-heart idea". J Clin Epidemiol. 48 (5): 713–719. PMID 7730926.
↑  
Kjaergard, LL; Gluud, C (2002). "Citation bias of hepato-biliary randomized clinical trials". J Clin Epidemiol. 55 (4): 407–410. PMID 11927219.
↑  
Schmidt, LM; Gøtzsche, PC (2005). "Of mites and men: reference bias in narrative review articles: a systematic review". J Fam Pract. 54 (4): 334–338. PMID 15833223.
↑  
Nieminen, P; Rucker, G; Miettunen, J; Carpenter, J; Schumacher, M (2007). "Statistically significant papers in psychiatry were cited more often than others". J Clin Epidemiol. 60 (9): 939–946. PMID 17689810.
↑  Pham, B; Klassen, TP; Lawson, ML; Moher, D (2005). "Language of publication restrictions in systematic reviews gave different results depending on whether the intervention was conventional or complementary". J Clin Epidemiol. 58 (8): 769–776. PMID 16086467.
↑  Juni, P; Holenstein, F; Sterne, J; Bartlett, C; Egger, M (2002). "Direction and impact of language bias of controlled trials: An empirical study". Int J Epidemiol. 31 (1): 115–123.
↑  Sterne, J.; Egger, M.; Moher, D. (2008). "Addressing reporting biases".  ใน Higgins, J. P. T.; Green, S. (บ.ก.). Cochrane handbook for systematic reviews of interventions. Chichester: Wiley. pp. 297–334. ISBN 978-0-470-69951-5.
↑  Chan, AW; Krleža-Jerić, K; Schmid, I; Altman, D (2004). "Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research". CMAJ. 171 (7): 735–740. PMID 15451835.
↑  Hemminki, E (1980). "Study of information submitted by drug companies to licensing authorities". BMJ. 280 (6217): 833–836. PMID 7370687.